Related Experiment Video
Updated: Oct 4, 2025

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Published on: October 24, 2019
From the dish to humans: A stem cell recipe for success
Holger A Russ1, Ali H Shilleh1, Lori Sussel1
1Barbara Davis Center for Diabetes, Department of Pediatrics, University of Colorado Anschutz Medical Campus, 1775 Aurora Court, Aurora, CO 80045, USA.
Abstract:
Islet transplantation has proven to be an effective treatment for type 1 diabetes (T1D) yet is hampered by the shortage of available tissue. Recently, two reports from a Viacyte multicenter clinical trial demonstrate the feasibility, safety, and potential efficacy of transplanting macro-encapsulated human stem cell-derived pancreatic endoderm cells into patients with T1D, highlighting the promise of a stem cell-based therapeutic approach.
Related Concept Videos
Stem Cell Culture
Embryonic Stem Cells
iPS Cell Differentiation

